Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Aclaris Therapeutics, Inc. (ACRS) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Aclaris Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1557746.
Total stock buying since 2015: $66,563,284.
Total stock sales since 2015: $93,234,304.
Total stock option exercises since 2015: $1,217,228.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 0 | $0 | 203,333 | $0 |
| 2024 | 4,975,718 | $6,464,603 | 0 | $0 | 611,768 | $211,990 |
| 2023 | 30,695 | $225,212 | 189,238 | $2,524,988 | 345,934 | $23,543 |
| 2022 | 0 | $0 | 366,930 | $5,877,226 | 339,367 | $0 |
| 2021 | 0 | $0 | 316,879 | $7,650,833 | 551,794 | $965,611 |
| 2020 | 0 | $0 | 0 | $0 | 654,531 | $0 |
| 2019 | 0 | $0 | 1,770,150 | $7,740,797 | 45,941 | $0 |
| 2018 | 431,743 | $4,960,358 | 17,300 | $337,996 | 60,847 | $2,098 |
| 2017 | 108,601 | $2,499,995 | 1,175,000 | $34,286,250 | 24,596 | $6,715 |
| 2016 | 23,440 | $453,811 | 1,446,619 | $34,816,214 | 14,078 | $7,271 |
| 2015 | 4,653,981 | $51,959,305 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-06 | 0 | $0 | 0 | $0 | 9,586 | $0 |
| 2025-05 | 0 | $0 | 0 | $0 | 9,467 | $0 |
| 2025-04 | 0 | $0 | 0 | $0 | 9,467 | $0 |
| 2025-02 | 0 | $0 | 0 | $0 | 79,967 | $0 |
| 2025-01 | 0 | $0 | 0 | $0 | 94,846 | $0 |
| 2024-12 | 0 | $0 | 0 | $0 | 340,090 | $180,636 |
| 2024-11 | 666,666 | $1,499,998 | 0 | $0 | 9,467 | $0 |
| 2024-10 | 0 | $0 | 0 | $0 | 9,467 | $0 |
| 2024-09 | 0 | $0 | 0 | $0 | 10,466 | $0 |
| 2024-08 | 373,569 | $472,761 | 0 | $0 | 53,015 | $31,354 |
| 2024-07 | 888,283 | $1,088,826 | 0 | $0 | 9,467 | $0 |
| 2024-06 | 3,047,200 | $3,403,018 | 0 | $0 | 46,746 | $0 |
| 2024-05 | 0 | $0 | 0 | $0 | 9,467 | $0 |
| 2024-04 | 0 | $0 | 0 | $0 | 9,467 | $0 |
| 2024-03 | 0 | $0 | 0 | $0 | 87,866 | $0 |
| 2024-02 | 0 | $0 | 0 | $0 | 26,250 | $0 |
| 2023-10 | 0 | $0 | 6,000 | $30,462 | 0 | $0 |
| 2023-09 | 9,490 | $74,971 | 0 | $0 | 1,000 | $0 |
| 2023-08 | 14,705 | $99,964 | 6,000 | $43,896 | 15,575 | $0 |
| 2023-07 | 0 | $0 | 0 | $0 | 15,000 | $0 |
| 2023-06 | 0 | $0 | 6,000 | $61,661 | 52,805 | $23,543 |
| 2023-03 | 6,500 | $50,277 | 91,971 | $1,149,887 | 250,304 | $0 |
| 2023-02 | 0 | $0 | 39,267 | $623,932 | 11,250 | $0 |
| 2023-01 | 0 | $0 | 40,000 | $615,150 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-06-06 | Milano Vincent | Option Ex | 4,793 | .00 | 0 |
| 2025-06-06 | Schiff Andrew N | Option Ex | 4,793 | .00 | 0 |
| 2025-05-01 | Walker Neal (CEO) | Option Ex | 9,467 | .00 | 0 |
| 2025-04-01 | Walker Neal (CEO) | Option Ex | 9,467 | .00 | 0 |
| 2025-02-01 | Balthaser Kevin (Chief Financial Officer) | Option Ex | 14,750 | .00 | 0 |
| 2025-02-01 | Monahan Joseph (Chief Scientific Officer) | Option Ex | 22,250 | .00 | 0 |
| 2025-02-01 | Loerop James (Chief Business Officer) | Option Ex | 33,500 | .00 | 0 |
| 2025-02-01 | Walker Neal (INTERIM CEO) | Option Ex | 9,467 | .00 | 0 |
| 2025-01-02 | Balthaser Kevin (Chief Financial Officer) | Option Ex | 13,200 | .00 | 0 |
| 2025-01-02 | Monahan Joseph (Chief Scientific Officer) | Option Ex | 17,380 | .00 | 0 |
| 2025-01-02 | Loerop James (Chief Business Officer) | Option Ex | 18,150 | .00 | 0 |
| 2025-01-02 | Walker Neal (INTERIM CEO) | Option Ex | 29,149 | .00 | 0 |
| 2025-01-01 | Balthaser Kevin (Chief Financial Officer) | Option Ex | 7,500 | .00 | 0 |
| 2025-01-01 | Walker Neal (INTERIM CEO) | Option Ex | 9,467 | .00 | 0 |
| 2024-12-31 | Balthaser Kevin (Chief Financial Officer) | Option Ex | 73,750 | .00 | 0 |
| 2024-12-31 | Monahan Joseph (Chief Scientific Officer) | Option Ex | 73,750 | .00 | 0 |
| 2024-12-31 | Loerop James (Chief Business Officer) | Option Ex | 73,750 | .00 | 0 |
| 2024-12-04 | Walker Neal (INTERIM CEO) | Option Ex | 118,840 | 1.52 | 180,636 |
| 2024-11-19 | Mehra Anand | Buy | 666,666 | 2.25 | 1,499,998 |
| 2024-11-01 | Walker Neal (INTERIM PRESIDENT AND CEO) | Option Ex | 9,467 | .00 | 0 |
| 2024-10-01 | Walker Neal (INTERIM PRESIDENT AND CEO) | Option Ex | 9,467 | .00 | 0 |
| 2024-09-01 | Balthaser Kevin (Chief Financial Officer) | Option Ex | 1,000 | .00 | 0 |
| 2024-09-01 | Walker Neal (INTERIM PRESIDENT AND CEO) | Option Ex | 9,466 | .00 | 0 |
| 2024-08-09 | Walker Neal (INTERIM PRESIDENT AND CEO) | Option Ex | 43,548 | .72 | 31,354 |
| 2024-08-05 | Leonard Braden Michael | Buy | 206,025 | 1.24 | 256,295 |
| 2024-08-02 | Leonard Braden Michael | Buy | 167,544 | 1.29 | 216,466 |
| 2024-08-01 | Walker Neal (INTERIM PRESIDENT AND CEO) | Option Ex | 9,467 | .00 | 0 |
| 2024-07-31 | Leonard Braden Michael | Buy | 100,000 | 1.33 | 132,600 |
| 2024-07-30 | Leonard Braden Michael | Buy | 173,730 | 1.30 | 226,370 |
| 2024-07-22 | Leonard Braden Michael | Buy | 17,716 | 1.33 | 23,562 |
| 2024-07-19 | Leonard Braden Michael | Buy | 6,689 | 1.30 | 8,695 |
| 2024-07-18 | Leonard Braden Michael | Buy | 130,317 | 1.30 | 169,542 |
| 2024-07-05 | Leonard Braden Michael | Buy | 123,017 | 1.15 | 141,346 |
| 2024-07-03 | Leonard Braden Michael | Buy | 143,288 | 1.16 | 166,070 |
| 2024-07-02 | Leonard Braden Michael | Buy | 86,092 | 1.14 | 98,489 |
| 2024-07-01 | Walker Neal (INTERIM PRESIDENT AND CEO) | Option Ex | 9,467 | .00 | 0 |
| 2024-07-01 | Leonard Braden Michael | Buy | 107,434 | 1.14 | 122,152 |
| 2024-06-28 | Leonard Braden Michael | Buy | 1,201,000 | 1.12 | 1,351,125 |
| 2024-06-27 | Leonard Braden Michael | Buy | 235,000 | 1.16 | 271,425 |
| 2024-06-13 | Leonard Braden Michael | Buy | 528,621 | 1.15 | 606,328 |
| 2024-06-12 | Leonard Braden Michael | Buy | 82,579 | 1.14 | 94,140 |
| 2024-06-11 | Leonard Braden Michael | Buy | 1,000,000 | 1.08 | 1,080,000 |
| 2024-06-01 | Humphries William D. | Option Ex | 4,660 | .00 | 0 |
| 2024-06-01 | Molineaux Christopher P. | Option Ex | 4,660 | .00 | 0 |
| 2024-06-01 | Walker Neal (INTERIM PRESIDENT AND CEO) | Option Ex | 9,466 | .00 | 0 |
| 2024-06-01 | Mehra Anand | Option Ex | 4,660 | .00 | 0 |
| 2024-06-01 | Reasons Bryan M. | Option Ex | 4,660 | .00 | 0 |
| 2024-06-01 | Powell Andrew Kenneth William | Option Ex | 4,660 | .00 | 0 |
| 2024-06-01 | Gowen Maxine | Option Ex | 4,660 | .00 | 0 |
| 2024-06-01 | Milano Vincent | Option Ex | 4,660 | .00 | 0 |
| 2024-06-01 | Schiff Andrew N | Option Ex | 4,660 | .00 | 0 |
| 2024-05-01 | Walker Neal (INTERIM PRESIDENT AND CEO) | Option Ex | 9,467 | .00 | 0 |
| 2024-04-01 | Walker Neal (INTERIM PRESIDENT AND CEO) | Option Ex | 9,467 | .00 | 0 |
| 2024-03-02 | Balthaser Kevin (Chief Financial Officer) | Option Ex | 1,500 | .00 | 0 |
| 2024-03-02 | Monahan Joseph (Chief Scientific Officer) | Option Ex | 12,500 | .00 | 0 |
| 2024-03-01 | Balthaser Kevin (Chief Financial Officer) | Option Ex | 3,475 | .00 | 0 |
| 2024-03-01 | Monahan Joseph (Chief Scientific Officer) | Option Ex | 60,925 | .00 | 0 |
| 2024-03-01 | Walker Neal (Interim President and CEO) | Option Ex | 9,466 | .00 | 0 |
| 2024-02-01 | Monahan Joseph (Chief Scientific Officer) | Option Ex | 7,500 | .00 | 0 |
| 2024-02-01 | Loerop James (Chief Business Officer) | Option Ex | 18,750 | .00 | 0 |
| 2023-10-23 | Monahan Joseph (Chief Scientific Officer) | Sale | 6,000 | 5.08 | 30,462 |
| 2023-09-06 | Balthaser Kevin (Chief Financial Officer) | Buy | 9,490 | 7.90 | 74,971 |
| 2023-09-01 | Balthaser Kevin (Chief Financial Officer) | Option Ex | 1,000 | .00 | 0 |
| 2023-08-28 | Loerop James (Chief Business Officer) | Buy | 14,705 | 6.80 | 99,964 |
| 2023-08-21 | Monahan Joseph (Chief Scientific Officer) | Sale | 6,000 | 7.32 | 43,896 |
| 2023-08-01 | Manion Douglas J. (Pres and CEO) | Option Ex | 15,575 | .00 | 0 |
| 2023-07-01 | Cawkwell Gail (Chief Medical Officer) | Option Ex | 15,000 | .00 | 0 |
| 2023-06-20 | Monahan Joseph (Chief Scientific Officer) | Sale | 6,000 | 10.28 | 61,661 |
| 2023-06-20 | Molineaux Christopher P. (Director) | Option Ex | 16,500 | 1.41 | 23,265 |
| 2023-06-15 | Molineaux Christopher P. (Director) | Option Ex | 249 | 1.12 | 278 |
| 2023-06-02 | Humphries William D. (Director) | Option Ex | 4,507 | .00 | 0 |
| 2023-06-02 | Molineaux Christopher P. (Director) | Option Ex | 4,507 | .00 | 0 |
| 2023-06-02 | Mehra Anand (Director) | Option Ex | 4,507 | .00 | 0 |
| 2023-06-02 | Reasons Bryan M. (Director) | Option Ex | 4,507 | .00 | 0 |
| 2023-06-02 | Powell Andrew Kenneth William (Director) | Option Ex | 4,507 | .00 | 0 |
| 2023-06-02 | Gowen Maxine (Director) | Option Ex | 4,507 | .00 | 0 |
| 2023-06-02 | Milano Vincent (Director) | Option Ex | 4,507 | .00 | 0 |
| 2023-06-02 | Schiff Andrew N (Director) | Option Ex | 4,507 | .00 | 0 |
| 2023-03-09 | Manion Douglas J. (Pres and CEO) | Buy | 6,500 | 7.74 | 50,277 |
| 2023-03-03 | Balthaser Kevin (Chief Financial Officer) | Sale | 894 | 12.63 | 11,289 |
| 2023-03-03 | Monahan Joseph (Chief Scientific Officer) | Sale | 16,037 | 12.63 | 202,611 |
| 2023-03-03 | Walker Neal (Director) | Sale | 30,240 | 12.63 | 382,082 |
| 2023-03-02 | Balthaser Kevin (Chief Financial Officer) | Sale | 1,000 | 12.29 | 12,289 |
| 2023-03-02 | Balthaser Kevin (Chief Financial Officer) | Option Ex | 1,500 | .00 | 0 |
| 2023-03-02 | Monahan Joseph (Chief Scientific Officer) | Sale | 14,800 | 12.37 | 183,031 |
| 2023-03-02 | Monahan Joseph (Chief Scientific Officer) | Option Ex | 12,500 | .00 | 0 |
| 2023-03-02 | Walker Neal (Director) | Sale | 29,000 | 12.37 | 358,585 |
| 2023-03-02 | Walker Neal (Director) | Option Ex | 18,254 | .00 | 0 |
| 2023-03-01 | Balthaser Kevin (Chief Financial Officer) | Option Ex | 4,950 | .00 | 0 |
| 2023-03-01 | Monahan Joseph (Chief Scientific Officer) | Option Ex | 74,675 | .00 | 0 |
| 2023-03-01 | Walker Neal (Director) | Option Ex | 138,425 | .00 | 0 |
| 2023-02-15 | Monahan Joseph (Chief Scientific Officer) | Sale | 5,000 | 13.06 | 65,310 |
| 2023-02-08 | Loerop James (Chief Business Officer) | Sale | 4,267 | 13.89 | 59,272 |
| 2023-02-02 | Walker Neal (Director) | Sale | 5,000 | 16.14 | 80,675 |
| 2023-02-01 | Loerop James (Chief Business Officer) | Option Ex | 11,250 | .00 | 0 |
| 2023-02-01 | Walker Neal (Director) | Sale | 25,000 | 16.75 | 418,675 |
| 2023-01-04 | Walker Neal (Director) | Sale | 15,000 | 14.89 | 223,350 |
| 2023-01-03 | Walker Neal (Director) | Sale | 25,000 | 15.67 | 391,800 |
| 2022-10-26 | Schiff Andrew N (Director) | Sale | 14,540 | 17.00 | 247,252 |
| 2022-10-25 | Schiff Andrew N (Director) | Sale | 12,018 | 17.02 | 204,522 |
| 2022-10-24 | Schiff Andrew N (Director) | Sale | 14,616 | 17.01 | 248,588 |
| 2022-10-18 | Schiff Andrew N (Director) | Sale | 32,093 | 16.89 | 542,018 |
| 2022-10-17 | Monahan Joseph (Chief Scientific Officer) | Sale | 5,000 | 15.98 | 79,910 |
| 2022-10-17 | Schiff Andrew N (Director) | Sale | 19,944 | 16.05 | 320,081 |
| 2022-10-07 | Schiff Andrew N (Director) | Sale | 7,324 | 16.16 | 118,348 |
| 2022-10-06 | Schiff Andrew N (Director) | Sale | 37,839 | 16.54 | 625,743 |
| 2022-10-04 | Schiff Andrew N (Director) | Sale | 7,700 | 16.01 | 123,261 |
| 2022-06-17 | Schiff Andrew N (Director) | Sale | 19,565 | 15.14 | 296,272 |
| 2022-06-03 | Humphries William D. (Director) | Option Ex | 3,356 | .00 | 0 |
| 2022-06-03 | Molineaux Christopher P. (Director) | Option Ex | 3,356 | .00 | 0 |
| 2022-06-03 | Mehra Anand (Director) | Option Ex | 3,356 | .00 | 0 |
| 2022-06-03 | Reasons Bryan M. (Director) | Option Ex | 3,356 | .00 | 0 |
| 2022-06-03 | Powell Andrew Kenneth William (Director) | Option Ex | 3,356 | .00 | 0 |
| 2022-06-03 | Gowen Maxine (Director) | Option Ex | 3,356 | .00 | 0 |
| 2022-06-03 | Milano Vincent (Director) | Option Ex | 3,356 | .00 | 0 |
| 2022-06-03 | Schiff Andrew N (Director) | Option Ex | 3,356 | .00 | 0 |
| 2022-04-25 | Walker Neal (President and CEO) | Sale | 20,000 | 15.18 | 303,660 |
| 2022-04-22 | Walker Neal (President and CEO) | Sale | 25,000 | 15.04 | 376,100 |
| 2022-04-21 | Walker Neal (President and CEO) | Sale | 25,000 | 15.24 | 380,950 |
| 2022-04-18 | Monahan Joseph (Chief Scientific Officer) | Sale | 30,000 | 16.28 | 488,310 |
| 2022-03-11 | Walker Neal (President and CEO) | Sale | 56,303 | 15.91 | 896,062 |
| 2022-03-10 | Monahan Joseph (Chief Scientific Officer) | Sale | 27,165 | 15.71 | 426,816 |
| 2022-03-10 | Ruffo Frank (Chief Financial Officer) | Sale | 12,823 | 15.54 | 199,333 |
| 2022-03-02 | Monahan Joseph (Chief Scientific Officer) | Option Ex | 12,500 | .00 | 0 |
| 2022-03-02 | Ruffo Frank (Chief Financial Officer) | Option Ex | 8,297 | .00 | 0 |
| 2022-03-02 | Walker Neal (President and CEO) | Option Ex | 18,254 | .00 | 0 |
| 2022-03-01 | Monahan Joseph (Chief Scientific Officer) | Option Ex | 63,750 | .00 | 0 |
| 2022-03-01 | Ruffo Frank (Chief Financial Officer) | Option Ex | 34,050 | .00 | 0 |
| 2022-03-01 | Walker Neal (President and CEO) | Option Ex | 114,425 | .00 | 0 |
| 2022-02-01 | Monahan Joseph (Chief Scientific Officer) | Option Ex | 1,050 | .00 | 0 |
| 2022-02-01 | Ruffo Frank (Chief Financial Officer) | Option Ex | 3,875 | .00 | 0 |
| 2022-02-01 | Walker Neal (President and CEO) | Option Ex | 10,800 | .00 | 0 |
| 2022-01-03 | Ali-jackson Kamil (Chief Legal Officer) | Option Ex | 45,518 | .00 | 0 |
| 2021-09-01 | Monahan Joseph (Chief Scientific Officer) | Option Ex | 2,333 | .00 | 0 |
| 2021-07-13 | Gordon David N. (Chief Medical Officer) | Sale | 2,631 | 16.98 | 44,674 |
| 2021-07-02 | Gordon David N. (Chief Medical Officer) | Option Ex | 6,000 | .00 | 0 |
| 2021-06-03 | Ali-jackson Kamil (Chief Legal Officer) | Sale | 9,492 | 21.96 | 208,425 |
| 2021-06-02 | Monahan Joseph (Chief Scientific Officer) | Sale | 21,790 | 21.91 | 477,375 |
| 2021-06-02 | Gordon David N. (Chief Medical Officer) | Sale | 37,914 | 21.88 | 829,558 |
| 2021-06-02 | Ruffo Frank (Chief Financial Officer) | Sale | 15,037 | 21.91 | 329,385 |
| 2021-06-02 | Walker Neal (President and CEO) | Sale | 33,260 | 21.91 | 728,560 |
| 2021-06-01 | Monahan Joseph (Chief Scientific Officer) | Option Ex | 50,000 | .00 | 0 |
| 2021-06-01 | Gordon David N. (Chief Medical Officer) | Sale | 14,000 | 23.14 | 323,974 |
| 2021-06-01 | Gordon David N. (Chief Medical Officer) | Option Ex | 87,500 | .00 | 0 |
| 2021-06-01 | Ruffo Frank (Chief Financial Officer) | Option Ex | 33,189 | .00 | 0 |
| 2021-06-01 | Walker Neal (President and CEO) | Option Ex | 73,015 | .00 | 0 |
| 2021-05-07 | Ali-jackson Kamil (Chief Legal Officer) | Sale | 5,416 | 23.61 | 127,855 |
| 2021-05-07 | Ali-jackson Kamil (Chief Legal Officer) | Option Ex | 5,416 | 10.66 | 57,734 |
| 2021-05-06 | Ali-jackson Kamil (Chief Legal Officer) | Sale | 15,000 | 23.59 | 353,835 |
| 2021-05-06 | Ali-jackson Kamil (Chief Legal Officer) | Option Ex | 15,000 | 10.66 | 159,900 |
Insider trading activities including stock purchases, stock sales, and option exercises of ACRS listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Aclaris Therapeutics, Inc. (symbol ACRS, CIK number 1557746) see the Securities and Exchange Commission (SEC) website.